Article Information
History
- June 13, 2024.
Article Versions
- Version 1 (June 7, 2024 - 11:07).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Fleur S.A. Wallis1,
- John L. Baker-Hernandez1,
- Marc van Tuil1,
- Claudia van Hamersveld1,
- Marco J. Koudijs1,
- Eugène T.P. Verwiel1,
- Alex Janse1,
- Laura S. Hiemcke-Jiwa1,2,
- Ronald R. de Krijger1,2,
- Mariëtte E.G. Kranendonk1,
- Marijn A. Vermeulen1,
- Pieter Wesseling1,3,
- Uta E. Flucke1,
- Valérie de Haas1,
- Maaike Luesink1,
- Eelco W. Hoving1,
- H. Josef Vormoor1,4,
- Max M. van Noesel1,5,
- Jayne Y. Hehir-Kwa1,
- Bastiaan B.J. Tops1,
- Patrick Kemmeren1,6,* and
- Lennart A. Kester1,*
- 1Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;
- 2Department of Pathology, UMC Utrecht, Utrecht, The Netherlands;
- 3Department of Pathology, Amsterdam University Medical Centers/ VUmc, Amsterdam, The Netherlands;
- 4Utrecht Cancer Center, UMC Utrecht, Utrecht, The Netherlands;
- 5Division Imaging & Cancer, UMC Utrecht, Utrecht, The Netherlands;
- 6Center for Molecular Medicine, UMC Utrecht & Utrecht University, Utrecht, the Netherlands;
- ↵*corresponding authors; email: l.a.kester{at}prinsesmaximacentrum.nl